Gartner, Inc. (IT) Operating Margin
- Operating margin · 12 months: Value 17.25%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 17.25% | Operating income / revenue. Period ending 2026-06-30. $1.12B ÷ $6.46B × 100 ≈ 17.25% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.12B USD | Operating Income (Loss) |
| Revenue | 6.46B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.96B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 3.05B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.12B | $6.46B | $1.96B | (m) | $3.05B | 17.25% |
| 2026-03-31 | $1.06B | $6.47B | $2.01B | (m) | $3.06B | 16.43% |
| 2025-12-31 | $1.03B | $6.50B | $2.05B | (m) | $3.07B | 15.79% |
| 2025-09-30 | $1.01B | $6.46B | $2.06B | (m) | $3.04B | 15.62% |
| 2025-06-30 | $1.17B | $6.42B | $2.06B | (m) | $2.99B | 18.20% |
| 2025-03-31 | $1.16B | $6.33B | $2.04B | (m) | $2.93B | 18.34% |
| 2024-12-31 | $1.16B | $6.27B | $2.02B | (m) | $2.88B | 18.45% |
| 2024-09-30 | $1.14B | $6.14B | $1.98B | (m) | $2.82B | 18.57% |
| 2024-06-30 | $1.14B | $6.06B | $1.95B | (m) | $2.77B | 18.78% |
| 2024-03-31 | $1.10B | $5.97B | $1.93B | (m) | $2.73B | 18.47% |
| 2023-12-31 | $1.24B | $5.91B | $1.90B | (m) | $2.70B | 20.94% |
| 2023-09-30 | $1.27B | $5.83B | $1.85B | (m) | $2.64B | 21.76% |
| 2023-06-30 | $1.28B | $5.75B | $1.81B | (m) | $2.60B | 22.21% |
| 2023-03-31 | $1.29B | $5.62B | $1.75B | (m) | $2.52B | 22.96% |
| 2022-12-31 | $1.10B | $5.48B | $1.69B | (m) | $2.48B | 20.09% |
| 2022-09-30 | $953.19M | $5.28B | $1.62B | (m) | $2.50B | 18.06% |
| 2022-06-30 | $929.99M | $5.10B | $1.56B | (m) | $2.40B | 18.23% |
| 2022-03-31 | $907.59M | $4.89B | $1.49B | (m) | $2.29B | 18.55% |
| 2021-12-31 | $915.75M | $4.73B | $1.44B | (m) | $2.16B | 19.34% |
| 2021-09-30 | $908.48M | $4.54B | $1.40B | (m) | $2.01B | 20.01% |
| 2021-06-30 | $765.91M | $4.38B | $1.37B | (m) | $2.02B | 17.49% |
| 2021-03-31 | $590.84M | $4.18B | $1.34B | (m) | $2.03B | 14.12% |
| 2020-12-31 | $490.15M | $4.10B | $1.35B | (m) | $2.04B | 11.96% |
| 2020-09-30 | $448.16M | $4.19B | $1.44B | (m) | $2.07B | 10.70% |
| 2020-06-30 | $429.66M | $4.20B | $1.48B | (m) | $2.06B | 10.24% |
| 2020-03-31 | $446.01M | $4.29B | $1.55B | (m) | $2.08B | 10.39% |
| 2019-12-31 | $370.09M | $4.25B | $1.55B | (m) | $2.10B | 8.72% |
| 2019-09-30 | $363.55M | $4.13B | $1.51B | (m) | $2.03B | 8.80% |
| 2019-06-30 | $347.13M | $4.05B | $1.48B | (m) | $1.97B | 8.57% |
| 2019-03-31 | $317.23M | $3.98B | $1.46B | (m) | $1.92B | 7.97% |
| 2018-12-31 | $259.71M | $3.98B | $1.47B | (m) | $1.88B | 6.53% |
| 2018-09-30 | $193.00M | $3.90B | (m) | (m) | $1.86B | 4.95% |
| 2018-06-30 | $115.93M | $3.81B | (m) | (m) | $1.84B | 3.04% |
| 2018-03-31 | $-68.55M | $3.65B | (m) | (m) | $1.78B | -1.88% |
| 2017-12-31 | $-6.33M | $3.31B | (m) | (m) | $1.60B | -0.19% |
| 2017-09-30 | $39.46M | $3.00B | (m) | (m) | $1.42B | 1.32% |
| 2017-06-30 | $112.54M | $2.75B | (m) | (m) | $1.27B | 4.10% |
| 2017-03-31 | $294.23M | $2.51B | (m) | (m) | $1.14B | 11.71% |
| 2016-12-31 | $305.14M | $2.44B | (m) | (m) | $1.09B | 12.48% |
| 2016-09-30 | $298.07M | $2.39B | (m) | (m) | $1.06B | 12.50% |
| 2016-06-30 | $301.82M | $2.31B | (m) | (m) | $1.02B | 13.06% |
| 2016-03-31 | $303.74M | $2.25B | (m) | (m) | $990.57M | 13.50% |
| 2015-12-31 | $288.00M | $2.16B | (m) | (m) | $962.68M | 13.31% |
| 2015-09-30 | $282.22M | $2.10B | (m) | (m) | $939.76M | 13.42% |
| 2015-06-30 | $279.13M | $2.07B | (m) | (m) | $920.43M | 13.46% |
| 2015-03-31 | $275.67M | $2.05B | (m) | (m) | $900.97M | 13.47% |
| 2014-12-31 | $286.16M | $2.02B | (m) | (m) | $876.07M | 14.16% |
| 2014-09-30 | $279.08M | $1.96B | (m) | (m) | $852.98M | 14.25% |
| 2014-06-30 | $288.43M | $1.90B | (m) | (m) | $817.50M | 15.20% |
| 2014-03-31 | $280.66M | $1.82B | (m) | (m) | $784.60M | 15.39% |
| 2013-12-31 | $275.49M | $1.78B | (m) | (m) | $760.46M | 15.44% |
| 2013-09-30 | $266.40M | $1.74B | (m) | (m) | $733.87M | 15.33% |
| 2013-06-30 | $257.42M | $1.70B | (m) | (m) | $717.21M | 15.13% |
| 2013-03-31 | $246.16M | $1.65B | (m) | (m) | $696.80M | 14.89% |
| 2012-12-31 | $245.71M | $1.62B | (m) | (m) | $678.84M | 15.21% |
| 2012-09-30 | $235.51M | $1.57B | (m) | (m) | $663.44M | 15.01% |
| 2012-06-30 | $232.99M | $1.54B | (m) | (m) | $647.02M | 15.13% |
| 2012-03-31 | $221.84M | $1.51B | (m) | (m) | $634.55M | 14.71% |
| 2011-12-31 | $214.06M | $1.47B | (m) | (m) | $613.71M | 14.58% |
| 2011-09-30 | $197.67M | $1.42B | (m) | (m) | $597.69M | 13.89% |
| 2011-06-30 | $183.19M | $1.37B | (m) | (m) | $576.71M | 13.34% |
| 2011-03-31 | $165.85M | $1.32B | (m) | (m) | $554.28M | 12.54% |
| 2010-12-31 | $149.26M | $1.29B | (m) | (m) | $543.17M | 11.58% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $134.48M | $1.14B | (m) | (m) | $477.00M | 11.80% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $164.37M | $1.28B | (m) | (m) | $514.99M | 12.85% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |